154 related articles for article (PubMed ID: 7012050)
1. Sulfonamides and sulfones in dermatologic therapy.
Bernstein JE; Lorincz AL
Int J Dermatol; 1981 Mar; 20(2):81-8. PubMed ID: 7012050
[No Abstract] [Full Text] [Related]
2. [Importance of the sulfonamides in the antibiotic era].
Otten H
Med Klin; 1971 Nov; 66(45):1514-7. PubMed ID: 5116746
[No Abstract] [Full Text] [Related]
3. [Glutathione reductase deficiency in Duhring's dermatitis herpetiformis].
Benöhr HC; Huelsekopf D; Kohn R
Hautarzt; 1973 Aug; 24(8):347-50. PubMed ID: 4741271
[No Abstract] [Full Text] [Related]
4. [Evaluation of sulfones in the treatment of dermatitis herpetiformis with particular reference to adverse effects].
Pawlik H; Placek W; Kwietniak K
Przegl Dermatol; 1980; 67(2):221-7. PubMed ID: 6996039
[No Abstract] [Full Text] [Related]
5. Update on the use of dapsone in dermatology.
Ghaoui N; Hanna E; Abbas O; Kibbi AG; Kurban M
Int J Dermatol; 2020 Jul; 59(7):787-795. PubMed ID: 31909480
[TBL] [Abstract][Full Text] [Related]
6. Innovative use of dapsone.
Wozel VE
Dermatol Clin; 2010 Jul; 28(3):599-610. PubMed ID: 20510768
[TBL] [Abstract][Full Text] [Related]
7. Dapsone and sulfapyridine.
Paniker U; Levine N
Dermatol Clin; 2001 Jan; 19(1):79-86, viii. PubMed ID: 11155588
[TBL] [Abstract][Full Text] [Related]
8. [Case of iatrogenic methemoglobinemia (due to 4,4-diamino-diphenylsulfone)].
Riceputi G; Biagioli R; Guardigni L; Dradi C; Pretolani E; Fabbri F
G Clin Med; 1979 Jun; 60(6):454-8. PubMed ID: 467879
[No Abstract] [Full Text] [Related]
9. Hypersensitivity reaction to dapsone: report from Malaysia.
Mohamed KN
Lepr Rev; 1984 Dec; 55(4):385-9. PubMed ID: 6527602
[No Abstract] [Full Text] [Related]
10. High dose dapsone toxicity.
Shelley WB; Goldwein MI
Br J Dermatol; 1976 Jul; 95(1):79-82. PubMed ID: 952745
[TBL] [Abstract][Full Text] [Related]
11. [Lip cyanosis in dapsone therapy: should the dosage be reduced?].
Stichtenoth D
MMW Fortschr Med; 2012 Apr; 154(6):32. PubMed ID: 22642026
[No Abstract] [Full Text] [Related]
12. Haemolytic effects of DDS in leprosy patients.
Khaire DS; Magar NG
Indian J Med Res; 1972 Oct; 60(10):1510-9. PubMed ID: 4661662
[No Abstract] [Full Text] [Related]
13. Sulfones and sulfonamides in dermatology today.
Lang PG
J Am Acad Dermatol; 1979 Dec; 1(6):479-92. PubMed ID: 528697
[TBL] [Abstract][Full Text] [Related]
14. [Management of dermatitis herpetiformis].
Schuppli R
Dtsch Med Wochenschr; 1968 Nov; 93(48):2343. PubMed ID: 4301398
[No Abstract] [Full Text] [Related]
15. Is dapsone safe?
Pettit JH
Int J Dermatol; 1981 Mar; 20(2):106-7. PubMed ID: 7216589
[No Abstract] [Full Text] [Related]
16. Dermatitis herpetiformis: effects of sulfones and sulfonamides on neutrophil myeloperoxidase-mediated iodination and cytotoxicity.
Kazmierowski JA; Ross JE; Peizner DS; Wuepper KD
J Clin Immunol; 1984 Jan; 4(1):55-64. PubMed ID: 6321539
[TBL] [Abstract][Full Text] [Related]
17. METHEMOGLOBINEMIA ASSOCIATED WITH THE INGESTION OF DIASONE.
FISHER I; ORKIN M
Arch Dermatol; 1965 Sep; 92():327. PubMed ID: 14329241
[No Abstract] [Full Text] [Related]
18. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.
Coleman MD; Rhodes LE; Scott AK; Verbov JL; Friedmann PS; Breckenridge AM; Park BK
Br J Clin Pharmacol; 1992 Sep; 34(3):244-9. PubMed ID: 1389948
[TBL] [Abstract][Full Text] [Related]
19. Hemolysis of red cells due to sulfone.
Mayer K; Ley AB
Ann Intern Med; 1970 May; 72(5):711-4. PubMed ID: 5448099
[No Abstract] [Full Text] [Related]
20. Drug resistance of Mycobacterium leprae, particularly to DDS.
Rees RJ
Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
